Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.

Zheng Quan Toh ORCID logo ; Beth Temple ; Tran Ngoc Huu ; Vo Thi Trang Dai ; Nguyen Trong Toan ; Doan Y Uyen ; Kathryn Bright ; Lien Anh Ha Do ; E Kim Mulholland ORCID logo ; Paul V Licciardi ORCID logo ; (2020) Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine. NPJ VACCINES, 5 (1). 76-. ISSN 2059-0105 DOI: 10.1038/s41541-020-00225-z
Copy

This brief communication describes the findings from a randomised controlled trial in Vietnam that co-administration of measles vaccine (MV) with 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix®, GSK) does not affect the immunogenicity of MV. These findings are most relevant for low- and middle-income countries (LMICs) in Asia considering PCV introduction.
Item Type Article
Elements ID 150507
Date Deposited 20 Mar 2021 11:46

Explore Further

picture_as_pdf
Brief communication immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine.pdf
subject
Published Version
Available under Creative Commons: Attribution 3.0
View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads